Skip to main content

Table 2 Remifentanil requirement for I-gel insertion during a TCI of propofol in PD group and NPD group

From: Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

 

PD Group (n = 24)

NPD Group (n = 23)

Dixon’s method EC50 (ng.ml−1)

2.38 ± 0.65

3.21 ± 0.49

Probit analysis

EC50 (ng.ml−1)

1.95 (1.52–2.36)

2.85 (2.26–3.41)

EC95 (ng.ml−1)

3.12 (2.53–5.84)

4.57 (3.72–8.54)

  1. Data from Dixon’s up-and-down method are presented as mean ± SD. Date from probit analysis are EC50 or EC95 with (95% confidence intervals)
  2. EC50 effective effect-site concentration in 50% of patients, EC95 effective effect-site concentration in 95% of patients
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us